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Introduction 
Unhealthy diet during pregnancy is a risk factor for a wide range of negative health and 
psychiatric outcomes [1]. For example, high-sugar and fat diets associate not only with 
increased risk for non-communicable diseases [2], such as diabetes and obesity, but also for 
neurodevelopmental disorders, such as attention deficit disorder (ADHD) and conduct 
problems (CP) [3]. In the nutritional field, epigenetics is an important area of investigation, as 
nutrients and bioactive compounds can alter the expression of genes at the transcriptional 
level [4]. Because epigenetic modifications, such as DNA methylation, can be passed on 
during cell division and result in long-term phenotypic changes [5], they also provide a 
framework for understanding the biological mechanisms through which pre- and postnatal 
environmental exposures may influence disease vulnerability [6,7].  
 In a recent paper [8], we examined how exposure to unhealthy fats (e.g. vegetable oils 
in fast foods) and sugars (e.g. sweets) might associate with ADHD symptoms in children who 
follow an early onset (≤ age 10; n=83) vs low (n=81) trajectory of CP, via DNA methylation 
of the insulin-like growth factor 2 (IGF2) gene. We focused on IGF2 due to its relevance in 
metabolic function [9], placental and fetal growth [10], and the development of brain regions 
implicated in ADHD [11-13].  Data was drawn from the Accessible Resource for Integrated 
Epigenomics Studies (ARIES) [14], a subsample of the Avon Longitudinal Study of Parents 
and Children (ALSPAC), which includes (a) maternal reports of diet (32 weeks gestation, age 
3 and 7); (b) peripheral measures of DNA methylation (Illumina 450k) at birth and age 7 
(n=671, 49% male) and (c) repeated assessments of psychiatric symptomatology, including 
CP (ages 4-13) and ADHD (ages 7-13). Below, we summarize our key findings before 
discussing limitations and future directions.  
 
Key findings  
1. Prenatal unhealthy diet and neonatal IGF2 methylation 
First, we found that a maternal unhealthy diet during pregnancy prospectively associated with 
higher IGF2 methylation at birth across all (i.e. both CP and typically developing) children, 
even after adjusting for a range of interrelated risk factors (e.g. maternal smoking, 
psychosocial and contextual risks).  This finding is consistent with previous research 
reporting an association between variation in offspring IGF2 methylation and prenatal dietary 
exposures, including periconceptional dietary supplementation (e.g. folic acid [15,16]; 
docosahexaenoic acid [17]), severe caloric restriction resulting from prenatal famine 
exposure [18], maternal obesity and BMI [17,19], as well as animal research on high-fat diet 
Epigenetics of Addiction 
3 
 
exposure [20]. The use of a prospective design additionally enabled us to examine 
longitudinal inter-relationships between unhealthy diet and IGF2 methylation, spanning 
gestation to mid-childhood. We found that (a) the association between diet and IGF2 
methylation was specific to pregnancy (i.e. not observed postnatally); and (b) whereas 
unhealthy diet showed high stability over time (i.e. what mothers ate in pregnancy related to 
what their children ate in childhood), IGF2 methylation did not. While these findings do not 
permit causal inference (see limitations), they do point to gestation as a potentially critical 
developmental window for diet-induced changes in IGF2 methylation, and suggest that IGF2 
methylation levels may be temporally dynamic.  
2. IGF2 methylation at birth and ADHD symptoms in childhood 
Second, we found that IGF2 methylation at birth prospectively associated with higher ADHD 
symptoms in childhood (age 7-13), but that this association was specific to CP children. 
Interestingly, this specificity was not due to differences in dietary exposure, as both groups 
showed comparable levels of prenatal unhealthy diet as well as IGF2 methylation at birth. 
Why would such a developmental risk pathway be specific to CP children? We know from a 
large body of literature that CP and ADHD are not only highly comorbid, but that this co-
occurrence is underpinned by greater genetic heritability and more severe environmental risk 
exposure, compared to either CP or ADHD alone [21,22]. Consequently, it is possible that, 
for CP children, the association between IGF2 methylation and ADHD may be compounded 
by unmeasured genetic influences (e.g. variability in IGF2, related imprinted loci, such as 
H19, and/or broader polygenic effects) as well as environmental factors beyond those 
controlled for in the analyses (e.g. air pollutants [23]).   
3. IGF2 methylation as a potential mediating mechanism 
Third, we found that among CP children, IGF2 methylation at birth mediated the effect of 
prenatal diet on ADHD symptomatology. This finding supports previous data from animal 
studies documenting an indirect pathway linking prenatal diet and postnatal outcomes, via 
IGF2 methylation. For example, Claycombe et al [20] reported that in male rats, combined 
exposure to intrauterine undernourishment and post-weaning high-fat diet associated with 
variation in IGF2 methylation and expression, which in turn related to lower insulin 
sensitivity and higher adipose tissue growth. Here, we extend findings by implicating IGF2 
methylation as a potential mechanism not only mediating vulnerability to physical/metabolic 
outcomes but also for ADHD risk, a neurodevelopmental psychiatric disorder. Of note, we 
found that mediation was specific to ADHD symptoms, and did not extend to other co-
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occurring symptoms (e.g. anxiety, depression) amongst CP children. Together, these findings 
are in line with the developmental origins of health and disease (DOHaD [7]) and latent 
vulnerability [24] hypotheses, whereby early risk exposure may alter biological systems in a 
way that may increase long-term vulnerability to physical and psychiatric disease.  
Limitations and future directions  
Conclusions drawn from our study are limited in a few important ways. First, ADHD and CP 
are complex, multi-determined psychiatric phenotypes. As such, other factors, such as genetic 
and environmental influences (beyond diet) are likely to be important.  Moreover, the IGF2 
gene is located in a highly dynamic region that includes multiple transcripts from alternative 
promoters, relates to different biological functions, and is differentially expressed across 
tissues and developmental periods, so that a more comprehensive epigenetic investigation in 
this gene will be required (e.g. contribution of histone modifications and microRNAs).  
 Second, we examined ADHD as a global construct. However, ADHD comprises of 
subdimensions of inattention, hyperactivity and impulsivity, and it will be of interest in future 
to establish whether effects may be general or domain-specific [25]. Third, although the use 
of peripheral tissue samples hold potential for the identification of exposure/risk biomarkers, 
the extent to which findings may reflect methylation changes in the brain is unclear. In fact, a 
recent study [26] found that most DNA methylation markers in peripheral blood do not 
reliably predict brain DNA methylation status, making inferences on brain-relevant processes 
difficult. As such, it will be important to establish to what extent peripheral levels of IGF2 
methylation relate to in vivo structural/functional neural markers of ADHD.  
 Fourth, more work will be needed to trace the specific biological pathways through 
which the observed effects manifest. The present findings allow only limited conclusions as 
to (a) how exactly diet affects IGF2 methylation, (b) why this effect is only observed 
prenatally, and (c) why associations with ADHD are observed only in children with co-
occurring CP. Addressing these questions will require the integration of intermediary 
variables, such as metabolites of nutrition, fetal growth trajectories (e.g. via sonar-doppler; 
[27]), transcriptomic data, early indicators of neurodevelopment, and in vivo brain imaging 
measures. The use of more comprehensive, repeated assessments of prenatal diet will also 
enable us to trace dietary effects on IGF2 methylation from early to late gestation, as well as 
examining the role of other important nutrients (e.g. folic acid).  Furthermore, the inclusion of 
genetic and environmental moderators may help to shed light on the specificity of ADHD risk 
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to CP children (e.g. via molecular designs to study single gene effects; or behavioural genetic 
designs to investigate diet interaction with genetic heritability as a whole). 
 Finally, because our study was based on correlational data, we were not able to 
establish causality. This will require the use of a multi-method approach for strengthening 
causal inference, including the implementation of (two-step) Mendelian Randomization [28], 
negative control (e.g. using paternal prenatal diet effects as a negative control to maternal 
effects) and cross-species designs.  
Implications and translational potential  
Data from our study and others suggest that IGF2 methylation may be sensitive to diet-
related exposures – particularly during pregnancy – and mediate vulnerability for negative 
developmental outcomes, such as ADHD risk. Although promising, this evidence is currently 
preliminary and in need of replication. Consequently, findings should be interpreted with 
caution and considered more as well-grounded hypotheses for further investigation. Bearing 
this in mind, there are a number of ways in which findings may be used in future to inform 
policy and practice.  In the first place, findings may refine existing models of how risk 
exposures, such as an unhealthy diet, become biologically embedded. Longitudinal modelling 
of environmental and epigenetic data may also be used to pinpoint specific windows of 
biological vulnerability (e.g. prenatal period) that may benefit most from preventive action. 
Evidence for diet-induced epigenetic effects may also highlight nutrition as an important 
modifiable intervention target. On the longer term, developments in knowledge, 
methodology, and research designs will offer exciting opportunities for delineating the role of 
IGF2 methylation on neurodevelopment, as well as testing its potential clinical utility as an 
exposure indicator, disease biomarker, and therapeutic target.  
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